Nautilus Biotechnology (NAUT) traded up 24.62 % during a 24 hours period ending at 07:44 PM Central Europe on Monday 26th. One Nautilus Biotechnology stock can currently be bought for about USD 2.46 on popular exchanges. Current supply of Nautilus Biotechnology stocks is 127.1 mn. Nautilus Biotechnology has a current market capitalization of USD 411.7 mn and approximately USD 44 mn worth of Nautilus Biotechnology was traded on exchanges in the last 24 hours. Since last month end, Nautilus Biotechnology has traded 226.94 % up. Simple moving average of last 200 days is at USD 2.1. The highest price of past 52 weeks was recorded at USD 4.31 on 03/25/2026. 52 weeks low was at USD 0.84 on 08/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Nrc Health (NRC) traded up 2.57 % and now trades at USD 22.28. Current market capitalisation for Nrc Health is USD 485.5 mn. Current price/earnings ratio for Nrc Health is 90.14.

  • Ares Acquisition Cl (AAC) traded down -0.5 % and now trades at USD 10.05. Ares Acquisition Cl has a market capitalisation of USD 491.7 mn.

  • Krispy Kreme (DNUT) traded down -4.41 % and now trades at USD 2.85. Krispy Kreme has a market capitalisation of USD 489.3 mn.

  • Churchill Capital Cl (XIIIU) traded flat 0 % and now trades at USD 10.4. Churchill Capital Cl has a market capitalisation of USD 491.2 mn.

  • Private Of America I (PBAM) traded down -0.92 % and now trades at USD 86.45. Current market capitalisation for Private Of America I is USD 492.4 mn. Private Of America I has a current price to earnings ratio of 10.73.

About Nautilus Biotechnology

Nautilus Biotechnology, Inc. is a life sciences company that specializes in proteomics with the aim of revolutionizing biomedical research and drug discovery. Based in Seattle, Washington, USA, the company strives to benefit patients and healthcare professionals globally through its cutting-edge technology and services. You can learn more about their work and offerings by visiting their website at www.nautilus.bio . Nautilus Biotechnology is Nasdaq-listed.